子宫内避孕器市场按设备类型、分销管道、最终用户和使用期限划分－2025-2032年全球预测

预计到 2032 年，子宫内避孕器市场规模将达到 47.6 亿美元，年复合成长率为 4.92%。

它清晰而权威地阐述了子宫内避孕器在现代避孕策略中的地位，并概述了报告的分析方法和价值。

子宫内避孕器（IUD）是现代避孕策略的基石，它提供长效、可逆的避孕效果，以满足不断变化的患者偏好和持续更新的临床指南。围绕这些技术的格局已不再局限于简单的铜製节育器与荷尔蒙节育器之争，而是涵盖了节育器设计、放置技术和术后护理通讯协定等方面的进步。临床医生、支付方和生产者都必须成功应对日益复杂的临床证据、监管、供应链动态和以患者为中心的医疗服务模式之间的相互作用。

深入探讨技术创新、监管重点以及病患和医疗保健服务偏好的转变如何重塑子宫内避孕器（IUD）的采用和使用。

子宫内避孕器（IUD）领域正经历一场变革，其驱动力来自于技术进步、临床指南的更新以及患者期望的改变。荷尔蒙和避孕器形态的创新延长了植入适应症的适用期，提高了患者的耐受性；同时，临床医生对产后早期和青少年时期植入子宫内避孕器的理解不断加深，也扩大了适用人群的范围。此外，远端医疗和数位化互动技术的进步正在重塑植入前咨询和追踪管道，从而实现以患者为中心的模式，减轻诊所负担，并提高患者对建议追踪计画的依从性。

评估2025年海关环境及贸易政策变化对子宫内避孕器供应链韧性、采购选择及临床可用性的影响

2025年实施的关税和贸易政策调整引入了新的变量，影响子宫内避孕器供应链的製造成本、分销计划和筹资策略。进口零件和原材料的关税增加了部分製造商的单位投入成本，促使他们采取短期应对措施，例如重新谈判供应商合约、策略性地建立库存以及选择性地转移部分生产活动。这些供应侧的调整凸显了弹性筹资策略的重要性，这些策略需要在成本、前置作业时间和品质保证要求之间取得平衡。

透过对设备类型、分销管道、临床环境和计划使用时长进行详细的細項分析，可以製定有针对性的策略和营运调整。

细分市场层面的趋势分析揭示了影响产品采纳和购买的许多细微因素，这些因素因设备特性、分销管道、终端用户环境和预期使用时长而异。按设备类型划分，市场可分为铜製和激素型两种，由于两者在副作用、非避孕益处以及对激素敏感患者的适用性方面存在差异，这种区分仍然是临床咨询和产品选择的关键驱动因素。当患者希望避免使用荷尔蒙或月经管理并非主要考虑因素时，铜製设备仍然是首选；而对于寻求减少经血量和月经等益处的患者，激素型设备往往是更佳选择。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

• 可生物降解子宫内避孕器的出现减少了取出程序和对环境的影响。
• 透过在农村地区整合远距远端医疗平台，提供子宫内避孕器远距咨询和发放服务
• 开发采用个人化剂量的新一代荷尔蒙释放型子宫内避孕器，以最大程度地减少副作用
• 越来越多的人开始使用数位健康追踪应用程式来监测子宫内避孕器的性能和用户满意度
• 透过公共卫生措施和补贴扩大新兴市场子宫内避孕器的可及性
• 在子宫内避孕器生产中过渡到环保包装材料，以实现永续性目标

第六章美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

8. 依器械类型分類的子宫内避孕器市场

• 铜
• 荷尔蒙

9. 按分销管道分類的子宫内避孕器市场

• 医院药房
• 网路药房
• 零售药房

第十章 以最终用户分類的子宫内避孕器市场

• 门诊手术中心
• 医院
• 专科诊所

第十一章 依使用时长分類的子宫内避孕器市场

• 5年或以上
• 3-5年
• 3年或以下

第十二章 各地区子宫内避孕器市场

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十三章 子宫内避孕器市场（依类别划分）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十四章 各国子宫内避孕器市场概况

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十五章 竞争格局

• 2024年市占率分析
• FPNV定位矩阵，2024
• 竞争分析
  • Bayer AG
  • CooperCompanies, Inc.
  • AbbVie Inc.
  • Pregna International Ltd.
  • Medicines360, Inc.
  • Shandong Weigao Medical Group Co., Ltd.
  • Chongqing Zhifei Biological Products Co., Ltd.
  • Shenzhen Salubris Pharmaceuticals Co., Ltd.
  • Gedeon Richter Plc.
  • BioFem Therapeutics, LLC

The Intrauterine Devices Market is projected to grow by USD 4.76 billion at a CAGR of 4.92% by 2032.

A clear and authoritative introduction situating intrauterine devices within modern contraceptive strategy and outlining the report's analytical approach and value

Intrauterine devices represent a cornerstone of modern contraceptive strategy, offering long-acting, reversible protection that aligns with evolving patient preferences and shifting clinical guidelines. The landscape surrounding these technologies has broadened beyond a simple copper versus hormonal dichotomy to encompass advances in device design, insertion techniques, and post-insertion care protocols. Clinicians, payers, and manufacturers alike must navigate an increasingly complex interplay of clinical evidence, regulatory scrutiny, supply chain dynamics, and patient-centered access models.

This executive summary synthesizes cross-cutting developments that are redefining how intrauterine devices are perceived, selected, and delivered across care settings. It situates recent technological refinements within real-world adoption patterns and operational constraints, highlighting the implications for training, procurement, and stakeholder communications. Readers will find a focused narrative that connects clinical efficacy and safety considerations to pragmatic commercial and policy questions, thereby enabling more informed decisions about product portfolios, distribution partnerships, and provider engagement strategies.

The following sections move from high-level shifts and policy impacts to granular segmentation and regional nuances, culminating in prescriptive recommendations and an accessible explanation of the research methods underpinning the analysis. Each element prioritizes clarity and applicability so that health system leaders, device manufacturers, and commercial strategists can translate insight into measurable actions.

A detailed exploration of how technological innovation, regulatory focus, and evolving patient and care delivery preferences are reshaping intrauterine device adoption and use

The landscape for intrauterine devices is undergoing transformative shifts driven by technological refinement, evolving clinical guidelines, and changing patient expectations. Innovations in hormonal formulations and device geometries are expanding insertion windows and improving tolerability, while growing clinician familiarity with immediate postpartum and adolescent insertion is broadening the pool of appropriate candidates. At the same time, advances in telehealth and digital engagement have reconfigured pre-insertion counseling and follow-up pathways, enabling more patient-centered models that reduce clinic burden and increase adherence to recommended follow-up schedules.

Concurrently, regulatory attention to safety surveillance and post-market studies has intensified, prompting manufacturers to invest more heavily in real-world evidence generation. This emphasis on longitudinal safety monitoring has elevated the importance of traceability, device registries, and harmonized adverse event reporting processes. Procurement and distribution models are shifting as well: centralized hospital purchasing is coexisting with an expansion of online pharmacy fulfillment and a renewed focus on ensuring continuity of supply for outpatient settings. These distribution shifts are altering commercial dynamics and reshaping the nature of partnerships between manufacturers, pharmacies, and provider organizations.

Importantly, patient preferences are changing; there is a stronger demand for reversible, long-acting contraception that minimizes systemic side effects and fits diverse reproductive plans. This has intensified investment in product differentiation and patient education initiatives, as manufacturers and providers seek to match device attributes to individual needs. The combined effect of technological, regulatory, and behavioral change is a market that rewards clinical evidence, ease of use, and access, and that penalizes slow adaptation to new care delivery models.

An assessment of the 2025 tariff environment and how trade policy changes are affecting supply chain resilience, procurement choices, and clinical availability of intrauterine devices

The imposition of tariffs and trade policy adjustments in 2025 has introduced a new variable that affects manufacturing costs, distribution planning, and procurement strategies across the intrauterine device supply chain. Tariffs on imported components and raw materials have raised unit input costs for some manufacturers, prompting near-term operational responses such as renegotiated supplier contracts, strategic inventory build-up, and selective relocation of certain manufacturing activities. These supply-side adjustments underscore the importance of a flexible procurement strategy that balances cost, lead time, and quality assurance requirements.

From a distribution perspective, tariffs have encouraged greater attention to sourcing diversification and to the feasibility of onshoring critical manufacturing steps. Health systems and purchasing organizations are reassessing supplier risk profiles and contingency plans to mitigate disruptions. Regulatory timelines for certifying relocated manufacturing lines or alternative component suppliers can introduce delays, requiring proactive engagement with authorities to validate equivalence and maintain continuity of supply.

Clinicians and provider networks may experience practical impacts in the form of changes to product assortments and availability at the point of care, which necessitates clearer communication with patients about device options. Procurement teams should evaluate long-term contracts and consider multi-sourcing strategies that preserve clinical choice while managing exposure to tariff-related cost volatility. In sum, the 2025 tariff environment necessitates a strategic response that integrates supply chain resilience, regulatory planning, and transparent stakeholder communication to sustain access and protect clinical continuity.

A granular segmentation analysis connecting device type, distribution pathway, clinical setting, and intended duration to inform targeted strategy and operational alignment

Segment-level dynamics reveal nuanced drivers of adoption and procurement that vary by device characteristics, distribution pathways, end-user environments, and intended duration of use. Based on Device Type, market is studied across Copper and Hormonal, and this distinction remains a primary determinant of clinical counseling and product selection because it aligns with differing side-effect profiles, non-contraceptive benefits, and suitability for patients with hormone sensitivities. Copper devices continue to appeal where hormone avoidance is desired and where menstrual management is less of a primary concern, while hormonal devices are often prioritized for patients seeking lighter bleeding patterns and amenorrhea-related benefits.

Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies, and each channel has unique implications for stock management, reimbursement navigation, and patient access models. Hospital pharmacies typically support immediate postpartum and inpatient insertion workflows and therefore prioritize on-hand availability and established clinician relationships. Online pharmacies are reshaping pre-procedure counseling and device procurement by facilitating remote ordering and discreet fulfillment, while retail pharmacies play a critical role in outpatient continuity and often bridge the gap between clinician recommendation and patient procurement.

Based on End User, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics, and the choice of end-user setting influences procedural protocols, training requirements, and device preference. Ambulatory surgical centers often emphasize efficiency and predictable device selection to streamline throughput, hospitals must balance inventory for both inpatient and outpatient insertion needs, and specialty clinics may focus on high-touch counseling and complex case management. Based on Usage Duration, market is studied across Over Five Years, Three To Five Years, and Under Three Years, and duration categories are central to product positioning, warranty and reimbursement conversations, and patient counseling. Long-duration devices align with goals of minimal maintenance and sustained efficacy, whereas shorter-duration options can appeal to patients seeking more frequent fertility planning or those trialing device tolerance.

Taken together, these segmentation lenses provide a framework for aligning clinical value propositions with distribution capabilities and end-user workflow requirements. Manufacturers and providers can leverage these insights to tailor messaging, optimize inventory placement, and design training that maps device attributes to specific clinical and operational contexts.

An in-depth regional synthesis showing how infrastructure, reimbursement frameworks, and cultural factors uniquely influence intrauterine device adoption and commercial approaches

Regional dynamics in intrauterine device utilization and commercial strategy reflect divergent healthcare infrastructures, reimbursement norms, and cultural attitudes toward contraception. In the Americas, clinical practice increasingly integrates long-acting reversible contraception into both routine gynecologic care and obstetric workflows, with a focus on immediate postpartum insertion and expanding provider training programs. Demand patterns in this region are shaped by a mix of public and private payers, variable access across rural and urban settings, and active policy discussions that influence coverage and procurement at the health system level.

In Europe, Middle East & Africa, the landscape is heterogeneous: established European markets emphasize rigorous post-market surveillance and incremental device innovation, while healthcare systems in parts of the Middle East and Africa face access constraints that prioritize cost-effective, robust supply chains and simplified training protocols. Stakeholders in this region must navigate a wide spectrum of regulatory pathways and health system maturity levels, which prompts differentiated commercial approaches that combine capacity building with targeted distribution partnerships.

In Asia-Pacific, growth in clinician training, increased awareness of long-acting contraceptive benefits, and expansion of outpatient care models are notable. Diverse regulatory environments and variations in public procurement mechanisms mean manufacturers often pursue country-specific strategies that address local reimbursement practices and cultural considerations regarding family planning. Across all regions, the interplay between urbanization, digital health adoption, and provider training programs is reshaping how devices are recommended, procured, and supported clinically, making regional customization a necessary component of effective market engagement.

A strategic overview of competitive positioning showing how clinical evidence, provider enablement, and distribution partnerships shape long-term leadership in the intrauterine device sector

Competitive dynamics among leading device makers and emerging challengers are increasingly defined by clinical differentiation, distribution agility, and investments in evidence generation. Firms that pair clear clinical advantages with robust post-market data and strong provider support programs generally achieve deeper integration into care pathways. Strategic alliances with pharmacies, hospital systems, and training consortia strengthen adoption by addressing practical barriers related to insertion competency, inventory management, and patient follow-up.

New entrants and niche players are focusing on distinct value propositions such as simplified insertion systems, reduced hormone exposure profiles, or novel materials designed to enhance tolerability. Established manufacturers respond by broadening educational outreach, expanding clinician training programs, and leveraging real-world data to substantiate safety and patient satisfaction claims. The competitive landscape therefore rewards a balanced approach that combines product-level innovation with meaningful investments in provider enablement and supply chain robustness.

Partnership models that integrate manufacturers with distribution networks and clinical training providers create durable advantages, particularly when they reduce time-to-provision for immediate postpartum insertions and outpatient procedures. Intellectual property portfolios remain relevant but are only one element of competitiveness; the ability to demonstrate consistent quality, regulatory compliance, and post-market vigilance increasingly determines long-term positioning. Companies that proactively manage lifecycle planning, clinician engagement, and evidence synthesis will be best placed to influence standard-of-care decisions and to sustain clinician and patient trust.

Actionable and high-impact recommendations for manufacturers and stakeholders to strengthen supply resilience, evidence generation, clinician training, and patient access across channels

Industry leaders should prioritize a set of pragmatic, high-impact actions to preserve access, protect clinical trust, and create differentiated value propositions. First, enhance supply chain resilience by diversifying component sourcing and by establishing validated contingency suppliers to mitigate tariff-related disruptions and other interruptions. This operational flexibility should be complemented by a clear regulatory roadmap for qualifying alternative manufacturing sites and materials to avoid clinical supply gaps.

Second, invest in robust post-market evidence programs that emphasize safety, patient-reported outcomes, and real-world performance across diverse populations and care settings. Such evidence supports clinical adoption, informs payer conversations, and strengthens brand credibility. Third, accelerate clinician training initiatives with a focus on immediate postpartum insertion, adolescent care, and outpatient insertion protocols; training should be modular, accessible, and tied to competency validation to ensure consistent clinical outcomes.

Fourth, align distribution strategies with evolving patient access models by combining traditional hospital pharmacy channels with online pharmacy engagement and targeted retail pharmacy partnerships. Ensure that patient counseling materials and digital tools are consistent across channels to reduce confusion and to protect continuity of care. Finally, adopt transparent pricing and contracting approaches that allow purchasers to plan around tariff volatility and that facilitate long-term supply agreements. Executing these recommendations will require cross-functional coordination between clinical affairs, regulatory, supply chain, and commercial teams, but will materially strengthen market position and patient access.

A transparent explanation of research sources, evidence triangulation, and methodological steps used to synthesize clinical, regulatory, and supply chain insights for intrauterine devices

This analysis is grounded in a multi-source research approach that synthesizes peer-reviewed clinical literature, regulatory filings, device labeling, expert clinician interviews, and a systematic review of supply chain and policy developments. Clinical insights derive from randomized trials, observational cohorts, and longitudinal safety registries, which were evaluated for methodological rigor and relevance to contemporary practice. Regulatory materials, including approvals and post-market surveillance summaries, were examined to identify emerging compliance trends and safety signals that affect product life-cycle management.

Commercial and operational conclusions are informed by structured interviews with clinicians, procurement leaders, and distribution partners, as well as by a thematic review of publicly available guidance on procurement and insertion protocols. Trade policy and tariff impacts were analyzed through a combination of import/export databases, customs classifications, and industry-reported responses to tariff changes, with attention to operational mitigations and supply chain realignment strategies. The research also incorporated an assessment of clinician training program design and digital engagement models to evaluate how these elements influence uptake and sustained use.

Throughout the analysis, findings were triangulated across multiple sources to ensure consistency, and limitations were explicitly documented, including potential regional data gaps and variability in service delivery models. Where uncertainties exist, the report highlights areas that would benefit from primary data collection or targeted market testing to validate strategic assumptions.

A concise conclusion synthesizing how clinical advances, supply resilience, and targeted market strategies collectively determine future intrauterine device accessibility and positioning

The intrauterine device landscape is at an inflection point where clinical innovation, changing care delivery models, and trade policy considerations converge to create both opportunity and complexity. Technological refinements and expanding clinical acceptance, particularly for immediate postpartum and adolescent insertion, are increasing the role of these devices in comprehensive reproductive health strategies. At the same time, supply chain sensitivity to tariffs and component sourcing underscores the need for operational agility and closer alignment between manufacturing, regulatory, and procurement functions.

Successful stakeholders will be those that build resilient supply networks, invest in rigorous post-market evidence, and deploy targeted clinician training while embracing modern patient access channels. Regional heterogeneity requires tailored approaches that reflect local regulatory environments and payer structures, and segmentation by device type, distribution channel, end user, and usage duration offers a practical blueprint for matching product attributes to patient and provider needs.

In conclusion, the next phase of intrauterine device evolution will reward enterprises that combine clinical credibility with operational excellence and that adopt transparent, patient-centered access strategies. By executing on the recommendations outlined in this summary, organizations can strengthen their positioning and contribute to expanded, equitable access to effective long-acting contraception.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Emergence of biodegradable intrauterine devices designed to reduce removal procedures and environmental impact
• 5.2. Integration of telemedicine platforms for remote counseling and prescription of IUDs in rural areas
• 5.3. Development of next-generation hormone-releasing IUDs with customized dosing to minimize side effects
• 5.4. Growing adoption of digital health tracking apps to monitor IUD performance and user satisfaction
• 5.5. Expansion of IUD accessibility in emerging markets driven by public health initiatives and subsidies
• 5.6. Shift toward eco-friendly manufacturing and packaging materials in IUD production to meet sustainability goals

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intrauterine Devices Market, by Device Type

• 8.1. Copper
• 8.2. Hormonal

9. Intrauterine Devices Market, by Distribution Channel

• 9.1. Hospital Pharmacies
• 9.2. Online Pharmacies
• 9.3. Retail Pharmacies

10. Intrauterine Devices Market, by End User

• 10.1. Ambulatory Surgical Centers
• 10.2. Hospitals
• 10.3. Specialty Clinics

11. Intrauterine Devices Market, by Usage Duration

• 11.1. Over Five Years
• 11.2. Three To Five Years
• 11.3. Under Three Years

12. Intrauterine Devices Market, by Region

• 12.1. Americas
  • 12.1.1. North America
  • 12.1.2. Latin America
• 12.2. Europe, Middle East & Africa
  • 12.2.1. Europe
  • 12.2.2. Middle East
  • 12.2.3. Africa
• 12.3. Asia-Pacific

13. Intrauterine Devices Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Intrauterine Devices Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2024
• 15.2. FPNV Positioning Matrix, 2024
• 15.3. Competitive Analysis
  • 15.3.1. Bayer AG
  • 15.3.2. CooperCompanies, Inc.
  • 15.3.3. AbbVie Inc.
  • 15.3.4. Pregna International Ltd.
  • 15.3.5. Medicines360, Inc.
  • 15.3.6. Shandong Weigao Medical Group Co., Ltd.
  • 15.3.7. Chongqing Zhifei Biological Products Co., Ltd.
  • 15.3.8. Shenzhen Salubris Pharmaceuticals Co., Ltd.
  • 15.3.9. Gedeon Richter Plc.
  • 15.3.10. BioFem Therapeutics, LLC

LIST OF FIGURES

• FIGURE 1. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 11. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. NORTH AMERICA INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 13. LATIN AMERICA INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. EUROPE INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. MIDDLE EAST INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. ASEAN INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. GCC INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. EUROPEAN UNION INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. BRICS INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. G7 INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. NATO INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. INTRAUTERINE DEVICES MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 28. INTRAUTERINE DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. INTRAUTERINE DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY COPPER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY COPPER, BY REGION, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY COPPER, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY COPPER, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY COPPER, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY COPPER, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY HORMONAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY HORMONAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY HORMONAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY HORMONAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY HORMONAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY HORMONAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY OVER FIVE YEARS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY OVER FIVE YEARS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY OVER FIVE YEARS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY OVER FIVE YEARS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY OVER FIVE YEARS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY OVER FIVE YEARS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY THREE TO FIVE YEARS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY THREE TO FIVE YEARS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY THREE TO FIVE YEARS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY THREE TO FIVE YEARS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY THREE TO FIVE YEARS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY THREE TO FIVE YEARS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY UNDER THREE YEARS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY UNDER THREE YEARS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY UNDER THREE YEARS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY UNDER THREE YEARS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY UNDER THREE YEARS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY UNDER THREE YEARS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 81. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 82. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 83. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 84. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 85. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 86. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 87. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 88. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 89. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 90. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 91. NORTH AMERICA INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 92. NORTH AMERICA INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 93. NORTH AMERICA INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 94. NORTH AMERICA INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 95. NORTH AMERICA INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 96. NORTH AMERICA INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 97. NORTH AMERICA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 98. NORTH AMERICA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 99. NORTH AMERICA INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 100. NORTH AMERICA INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 101. LATIN AMERICA INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 102. LATIN AMERICA INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 103. LATIN AMERICA INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 104. LATIN AMERICA INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 105. LATIN AMERICA INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 106. LATIN AMERICA INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 107. LATIN AMERICA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 108. LATIN AMERICA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 109. LATIN AMERICA INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 110. LATIN AMERICA INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 111. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 112. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 113. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 114. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 115. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 116. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 117. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 118. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 119. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 120. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 121. EUROPE INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 122. EUROPE INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 123. EUROPE INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 124. EUROPE INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 125. EUROPE INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 126. EUROPE INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 127. EUROPE INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 128. EUROPE INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 129. EUROPE INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 130. EUROPE INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 131. MIDDLE EAST INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 132. MIDDLE EAST INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 133. MIDDLE EAST INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 134. MIDDLE EAST INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 135. MIDDLE EAST INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 136. MIDDLE EAST INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 137. MIDDLE EAST INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 138. MIDDLE EAST INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 139. MIDDLE EAST INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 140. MIDDLE EAST INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 141. AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 142. AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 143. AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 144. AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 145. AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 146. AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 147. AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 148. AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 149. AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 150. AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 151. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 152. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 153. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 154. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 155. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 156. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 157. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 158. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 159. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 160. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 161. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 162. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 163. ASEAN INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 164. ASEAN INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 165. ASEAN INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 166. ASEAN INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 167. ASEAN INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 168. ASEAN INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 169. ASEAN INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 170. ASEAN INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 171. ASEAN INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 172. ASEAN INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 173. GCC INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 174. GCC INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 175. GCC INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 176. GCC INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 177. GCC INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 178. GCC INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 179. GCC INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 180. GCC INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 181. GCC INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 182. GCC INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 183. EUROPEAN UNION INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 184. EUROPEAN UNION INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 185. EUROPEAN UNION INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 186. EUROPEAN UNION INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 187. EUROPEAN UNION INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 188. EUROPEAN UNION INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 189. EUROPEAN UNION INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 190. EUROPEAN UNION INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 191. EUROPEAN UNION INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 192. EUROPEAN UNION INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 193. BRICS INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 194. BRICS INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 195. BRICS INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 196. BRICS INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 197. BRICS INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 198. BRICS INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 199. BRICS INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 200. BRICS INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 201. BRICS INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 202. BRICS INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 203. G7 INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 204. G7 INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 205. G7 INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 206. G7 INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 207. G7 INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 208. G7 INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 209. G7 INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 210. G7 INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 211. G7 INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 212. G7 INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 213. NATO INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 214. NATO INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 215. NATO INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 216. NATO INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 217. NATO INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 218. NATO INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 219. NATO INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 220. NATO INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 221. NATO INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 222. NATO INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 223. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 224. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 225. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 226. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 227. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 228. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 229. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 230. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 231. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 232. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 233. CANADA INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 234. CANADA INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 235. CANADA INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 236. CANADA INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 237. CANADA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 238. CANADA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 239. CANADA INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 240. CANADA INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 241. MEXICO INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 242. MEXICO INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 243. MEXICO INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 244. MEXICO INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 245. MEXICO INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 246. MEXICO INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 247. MEXICO INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 248. MEXICO INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 249. BRAZIL INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 250. BRAZIL INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 251. BRAZIL INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 252. BRAZIL INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 253. BRAZIL INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 254. BRAZIL INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 255. BRAZIL INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 256. BRAZIL INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 257. UNITED KINGDOM INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 258. UNITED KINGDOM INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 259. UNITED KINGDOM INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 260. UNITED KINGDOM INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 261. UNITED KINGDOM INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 262. UNITED KINGDOM INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 263. UNITED KINGDOM INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 264. UNITED KINGDOM INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 265. GERMANY INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 266. GERMANY INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 267. GERMANY INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 268. GERMANY INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 269. GERMANY INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 270. GERMANY INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 271. GERMANY INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 272. GERMANY INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 273. FRANCE INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 274. FRANCE INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 275. FRANCE INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 276. FRANCE INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 277. FRANCE INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 278. FRANCE INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 279. FRANCE INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 280. FRANCE INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 281. RUSSIA INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 282. RUSSIA INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 283. RUSSIA INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 284. RUSSIA INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 285. RUSSIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 286. RUSSIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 287. RUSSIA INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 288. RUSSIA INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 289. ITALY INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 290. ITALY INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 291. ITALY INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 292. ITALY INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 293. ITALY INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 294. ITALY INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 295. ITALY INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 296. ITALY INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 297. SPAIN INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 298. SPAIN INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 299. SPAIN INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 300. SPAIN INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 301. SPAIN INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 302. SPAIN INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 303. SPAIN INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 304. SPAIN INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 305. CHINA INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 306. CHINA INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 307. CHINA INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 308. CHINA INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 309. CHINA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 310. CHINA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 311. CHINA INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 312. CHINA INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 313. INDIA INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 314. INDIA INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 315. INDIA INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 316. INDIA INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 317. INDIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 318. INDIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 319. INDIA INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 320. INDIA INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 321. JAPAN INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 322. JAPAN INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 323. JAPAN INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 324. JAPAN INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 325. JAPAN INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 326. JAPAN INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 327. JAPAN INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 328. JAPAN INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 329. AUSTRALIA INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 330. AUSTRALIA INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 331. AUSTRALIA INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 332. AUSTRALIA INTRAUTERINE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 333. AUSTRALIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 334. AUSTRALIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 335. AUSTRALIA INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 336. AUSTRALIA INTRAUTERINE DEVICES MARKET SIZE, BY USAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 337. SOUTH KOREA INTRAUTERINE DEVICES MARKET SIZE, BY DEVICE TYPE